Rep. Ilhan Omar of Minnesota said that marijuana use may be more widespread among lawmakers than publicly acknowledged, as she also renewed calls for broader legalization nationwide.

Speaking to TMZ in Washington, D.C., Omar — who serves as co-chair of the Congressional Cannabis Caucus — addressed ongoing discussions surrounding medical and recreational marijuana research. When asked whether it was surprising that no members of Congress openly identify as regular marijuana users, she suggested that advocacy and personal use are not necessarily connected.

“I will say –– advocacy for legalizing doesn’t necessarily mean that you are a user, so everybody can be an advocate to legalizing it because we understand that it is not OK for us to spend the billions of dollars we do now in incarcerating people for smoking a joint,” she said.

Pressed further on whether lawmakers themselves use cannabis, Omar laughed and indicated she believes such behavior is not uncommon on Capitol Hill.

“I think there are a lot of people who smoke cannabis in Congress,” she said, flashing a peace sign before ending the exchange.

Omar also argued that federal law should catch up with state-level changes, noting that many states have already legalized marijuana in some form. She pointed to President Donald Trump’s role in shifting Republican attitudes on drug policy and encouraging more dialogue within the party.

“I think any step forward is a good step, but we need to go farther than where we are yet,” she said. “We need to continue building the coalition, we need to continue to have people speak to the president. He has the power, Congress has the power, and it’s time for us to come together and get this done.”

Recent actions by the Trump administration reflect a broader shift in federal policy toward marijuana and psychedelic drugs. Last month, Trump signed an executive order easing restrictions on research into psychedelic substances, particularly for treating conditions such as depression and substance abuse.

The order also instructed the Food and Drug Administration to accelerate its review process, leading to approvals for certain psychedelic-based treatments. Several Republican lawmakers, including Reps. Morgan Luttrell of Texas and Jack Bergman of Michigan, have advocated for making such treatments available to veterans.

Shortly afterward, Acting Attorney General Todd Blanche directed that state-approved medical marijuana be reclassified as less dangerous, aligning with what officials described as the president’s “promise to expand Americans’ access to medical treatment options.”

The move reduced regulatory burdens on medical marijuana and introduced tax benefits for licensed providers.

“These actions will enable more targeted, rigorous research into marijuana’s safety and efficacy, expanding patients’ access to treatments and empowering doctors to make better-informed healthcare decisions,” Blanche said in his announcement at the time, posted to the social platform X.

While these developments have not significantly altered the legal status of recreational marijuana at the federal level, they represent a notable departure from the strict enforcement approach that defined the decades-long “war on drugs” launched during the Nixon administration.

{Matzav.com}